These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2982093)

  • 1. Safety of the hepatitis B vaccine.
    Stevens CE; Taylor PE; Rubinstein P; Ting RC; Bodner AJ; Sarngadharan MG; Gallo RC
    N Engl J Med; 1985 Feb; 312(6):375-6. PubMed ID: 2982093
    [No Abstract]   [Full Text] [Related]  

  • 2. No HTLV-III antibodies after HBV vaccination.
    Muylle L; Vranckx P; Peetermans ME
    N Engl J Med; 1986 Feb; 314(9):581. PubMed ID: 2935739
    [No Abstract]   [Full Text] [Related]  

  • 3. HTLV-III antibodies after hepatitis B vaccination.
    Kessler H; Chase R; Harris A; Jensen D; Levin S
    Lancet; 1985 Jun; 1(8444):1506-7. PubMed ID: 2861432
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
    Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A
    J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of the hepatitis B vaccine. Inactivation of the AIDS virus during routine vaccine manufacture.
    Francis DP; Feorino PM; McDougal S; Warfield D; Getchell J; Cabradilla C; Tong M; Miller WJ; Schultz LD; Bailey FJ
    JAMA; 1986 Aug; 256(7):869-72. PubMed ID: 3016352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release potency tests of hepatitis vaccines.
    Descamps J; Mary A; Rommel E; Anhoury ML; De Neys R; Duchêne M
    Dev Biol Stand; 1999; 101():289-94. PubMed ID: 10566803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of AIDS in recipients of hepatitis B vaccine.
    Papaevangelou G; Kallinikos G; Roumeliotou A; Politou K
    N Engl J Med; 1985 Feb; 312(6):376-7. PubMed ID: 3155823
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B vaccine contract goes to untested product.
    Ryan M
    Nature; 1987 Sep 3-9; 329(6134):6. PubMed ID: 2957594
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B vaccine: evidence confirming lack of AIDS transmission.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Dec; 33(49):685-7. PubMed ID: 6239091
    [No Abstract]   [Full Text] [Related]  

  • 10. [Limited value of anti-HBs determination following vaccination against hepatitis B].
    Heijtink RA
    Ned Tijdschr Geneeskd; 1987 Aug; 131(33):1443-4. PubMed ID: 2959868
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous administration of hepatitis B and yellow fever vaccines.
    Yvonnet B; Coursaget P; Deubel V; Diop-Mar I; Digoutte JP; Chiron JP
    Dev Biol Stand; 1986; 65():205-7. PubMed ID: 2951287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of active immunization against hepatitis B infections.
    Gust ID
    Malays J Pathol; 1985 Aug; 7():1-6. PubMed ID: 2952843
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune response to hepatitis B vaccination in haemodialysis patients and healthy medical staff.
    Ton SH; Duraisamy G; Noriah R; Thiruselvam A; Lopez CG; Suleiman AB
    Singapore Med J; 1986 Apr; 27(2):120-3. PubMed ID: 2944217
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS virus antibody in polytransfused dialysis patients vaccinated against hepatitis B.
    Desmyter J; Reynders M; Goubau P
    Br Med J (Clin Res Ed); 1986 Aug; 293(6546):537. PubMed ID: 3019458
    [No Abstract]   [Full Text] [Related]  

  • 15. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The trial preparation of attenuated live hepatitis A vaccine].
    Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):1-6. PubMed ID: 2548744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination.
    Fagan EA; Williams R
    Br J Clin Pract; 1987 Jan; 41(1):569-76. PubMed ID: 2959306
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of hepatitis B vaccine confirmed.
    FDA Drug Bull; 1985 Aug; 15(2):14-5. PubMed ID: 2996962
    [No Abstract]   [Full Text] [Related]  

  • 20. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.